首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection.
【24h】

Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection.

机译:通过在鼠类侵袭性感染中测试具有各种伊曲康唑敏感性的假丝酵母菌株,将伊曲康唑静脉和口服增溶制剂的体外活性与体内功效相关联。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To examine whether in vitro antifungal susceptibility test results correlate with in vivo efficacy of two cyclodextrin-solubilized itraconazole formulations (intravenous and oral) against Candida in a murine model of invasive infection. METHODS: A selected set of 12 Candida spp. strains with various itraconazole susceptibilities were tested. We studied the efficacy of intravenous and oral itraconazole administered once daily at dosages of 0.63, 2.5, 10 and 40 mg/kg body weight in mice lethally infected with each tested strain. Survival of mice in each treated group was monitored daily until the death of all control mice and compared between groups. RESULTS: Survival of mice infected with 9 of 12 Candida strains with itraconazole MICs of
机译:目的:在小鼠侵袭性感染模型中,检查体外抗真菌药敏试验结果是否与两种环糊精增溶的伊曲康唑制剂(静脉和口服)对念珠菌的体内疗效相关。方法:选择一组12个念珠菌属。测试了具有各种伊曲康唑敏感性的菌株。我们研究了以0.63、2.5、10和40 mg / kg体重的剂量每天一次静脉和口服伊曲康唑在致死性感染每种测试菌株的小鼠中的功效。每天监测每个治疗组中小鼠的存活,直到所有对照小鼠死亡,并在各组之间进行比较。结果:以2.5或10 mg / kg及以上的剂量静脉注射伊曲康唑治疗,感染12株念珠菌菌株中有9株伊曲康唑MIC≤0.016-2.0mg / L的小鼠的存活期显着延长。相反,即使在最高伊曲康唑剂量(40 mg / kg)的情况下,体外对8 mg / L伊曲康唑耐药的其他三株菌株也对该疗法具有耐药性。口服伊曲康唑治疗获得了非常相似的体内数据。两种伊曲康唑制剂的有效剂量随着伊曲康唑MICs的增加而增加。结论:静脉和口服伊曲康唑的体内疗效与体外药敏数据相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号